Comparison between intravenous and intraarterial contrast injections for dynamic 3D MRI of liver tumors in the VX2 rabbit model

Journal of Magnetic Resonance Imaging

Volumn 24, Issue 1, 2006, Pages 242-247

  Larson, Andrew C ^a,b   Rhee, Thomas K ^a   Deng, Jie ^a,b   Wang, Dingxin ^a,b   Sato, Kent T ^a   Salem, Riad ^a   Paunesku, Tatjana ^a   Woloschak, Gayle ^a   Mulcahy, Mary F ^a   Li, Debiao ^a,b   Omary, Reed A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

Author keywords

Contrast injection; Intraarterial; Liver; MRI; Tumor; VX2

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; INTERMETHOD COMPARISON; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING; TUMOR DIAGNOSIS; X RAY;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; GADOLINIUM DTPA; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM TRANSPLANTATION; RABBITS;

EID: 33745728284     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20623     Document Type: Article

References (23)

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127(5 Suppl 1): S5-S16.
2. Di Bisceglie AM. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Intervent Radiol 2002;13(9 Pt 2):S169-S171.
3. Marcos-Alvarez A, Jenkins RL, Washburn WK, et al. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg 1996;131:292-298.
4. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004;127(5 Suppl 1):S248-S260.
5. Ahmed M, Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Intervent Radiol 2002;13(9 Pt 2):S231-S244.
6. Ueda K, Kitagawa K, Kadoya M, Matsui O, Takashima T, Yamahana T. Detection of hypervascular hepatocellular carcinoma by using spiral volumetric CT: comparison of US and MR imaging. Abdom Imaging 1995;20:547-553.
7. Rode A, Bancel B, Douek P, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327-336.
8. Bartolozzi C, Lencioni R, Caramella D, Palla A, Bassi AM, Di Candio G. Small hepatocellular carcinoma. Detection with US. CT, MR imaging, DSA, and Lipiodol-CT. Acta Radiol 1996;37:69-74.
9. Burrel M, Llovet JM, Ayuso C, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003;38:1034-1042.
10. Taouli B, Losada M, Holland A, Krinsky G. Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S144-S152.
11. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
12. Teefey SA, Hildeboldt CC, Dehdashti F, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 2003;226: 533-542.
13. Chalasani N, Horlander Sr JC, Said A, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999;94:2988-2993.
14. Runge VM. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model. Invest Radiol 1998;33:263-267.
15. Ackerman NB. Experimental studies on the circulation dynamics of intrahepatic tumor blood supply. Cancer 1972;29:435-439.
16. Takayasu K, Maeda T, Iwata R. Sensitivity of superselective arteriography for small hepatocellular carcinoma compared with proximal arteriography and computed tomography during superselective arteriography. Jpn J Clin Oncol 2002;32:191-195.
17. Tennant BC, Toshkov LA, Peek SF, et al. Hepatocellular carcinoma In the woodchuck model of hepatitis B virus infection. Gastroenterology 2004;127(5 Suppl 1):S283-293.
18. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000;11:1245-1255.
19. Ramirez LH, Julieron M, Bonnay M, et al. Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model. Invest New Drugs 1995;13:51-53.
20. Green JD, Omary RA, Finn JP, et al. Two- and three-dimensional MR coronary angiography with intraarterial injections of contrast agent in dogs: a feasibility study. Radiology 2003;226:272-277.
21. Green JD, Schirf BE, Omary RA, McCarthy RM, Carr JC, Li D. Projection imaging of the right coronary artery with an intravenous injection of contrast agent. Magn Reson Med 2004;52:699-703.
22. Rhee TK, Omary RA, Gates V, et al. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Intervent Radiol 2005;16:1085-1091.
23. de Crespigny AJ, Howard D, D'Arceuil H, et al. Dynamic contrast-enhanced MRI of Implanted VX2 tumors in rabbit muscle: comparison of Gd-DTPA and NMS60. Magn Reson Imaging 1999;17:1297-1305.